Last reviewed · How we verify
PD-L1 PET Imaging in Melanoma Patients
This is a feasibility study for the use of \[18F\]PD-L1 as a PET tracer that will be conducted in a single center. The study consists of two phases. The aim of phase one is to provide pharmacokinetic information on the tracer and to determine the optimal time point for imaging. In the second phase the main study objective will be assessed.
Details
| Lead sponsor | University Medical Center Groningen |
|---|---|
| Phase | NA |
| Status | COMPLETED |
| Enrolment | 10 |
| Start date | Mon May 22 2017 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Mon Apr 12 2021 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Melanoma
Interventions
- PD-L1 PET imaging
Countries
Netherlands